WebDisclosure WebDisclosure
Basculer en Français
10472 Companies
220523 Keywords
149850 Articles
116617 Press releases
Headlines Articles Press releases Dr. Falk Pharma GmbH Remove
  1. Home
  2. Companies
  3. Dr. Falk Pharma GmbH
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 10/29/2024 at 13:05, 1 year 7 months ago

    Dr. Falk Pharma Acquires Kynos Therapeutics, Enhancing Portfolio in Inflammatory Diseases

    Inflammatory Diseases Dr. Falk Pharma Kynos Therapeutics Acute Pancreatitis KNS366
  • BRIEF

    published on 10/29/2024 at 13:05, 1 year 7 months ago

    Dr. Falk Pharma acquiert Kynos Therapeutics, enrichissant ainsi son portefeuille dans le domaine des maladies inflammatoires

    Maladies Inflammatoires Dr. Falk Pharma KNS366 Thérapeutique Kynos Pancréatite Aiguë
  • PRESS RELEASE

    published on 10/29/2024 at 13:00, 1 year 7 months ago

    Dr. Falk Pharma Acquires Kynos Therapeutics, Adding Acute Pancreatitis as a Therapeutic Focus and Further Strengthening Its Development Portfolio

    Dr. Falk Pharma GmbH acquires Kynos Therapeutics Ltd., focusing on inflammatory disease treatments. KNS366, a novel enzyme inhibitor, shows promise in clinical trials for acute pancreatitis
    Inflammatory Diseases Dr. Falk Pharma Kynos Therapeutics Acute Pancreatitis KNS366
    Logo of Dr. Falk Pharma GmbH
Accesswire
  • Published on 05/29/2026 at 15:50, 4 hours 33 minutes ago

    Power Metallic Mines Announces Upsize of Brokered LIFE Offering for Gross Proceeds of up to C$30 Million

  • Published on 05/29/2026 at 14:30, 5 hours 53 minutes ago

    Sarama Completes Tranche 1 Equity Placement and ASX Cleansing Notice

  • Published on 05/29/2026 at 14:30, 5 hours 53 minutes ago

    Unusual Machines to Participate in June Investor Conferences

  • Published on 05/29/2026 at 14:20, 6 hours 3 minutes ago

    Ansell Announces Greenovation(TM) Awards for Sustainability Leadership and Waste Reduction

  • Published on 05/29/2026 at 13:59, 6 hours 24 minutes ago

    AIP Realty Trust Announces First Quarter 2026 Results

View all ACCESSWIRE
EQS Group
  • Published on 05/29/2026 at 20:00, 23 minutes ago

    Brödernas publishes quarterly report for Jan-Mar 2026

  • Published on 05/29/2026 at 19:46, 36 minutes ago

    CPI PROPERTY GROUP publishes financial results for the first quarter of 2026

  • Published on 05/29/2026 at 19:27, 55 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 05/29/2026 at 19:18, 1 hour 5 minutes ago

    EQS-Adhoc: Ludwig Beck am Rathauseck-Textilhaus Feldmeier AG: Change to the shareholding structure

  • Published on 05/29/2026 at 18:50, 1 hour 33 minutes ago

    EQS-Adhoc: fox e-mobility AG: Capital Increase and Debt Reduction at Fox Automotive Switzerland AG – Adjustment of Shareholding Value – Departure of Philippe Perret – Financial Reports – Annual General Meeting D

View all EQS
Les Echos
  • Published on 05/29/2026 at 18:00, 2 hours 23 minutes ago

    Recticel Group versnelt groei in isolatiepanelen met geïntegreerde isothermische oplossingen na overname Isopanel NV

  • Published on 05/29/2026 at 18:00, 2 hours 23 minutes ago

    Recticel Group acquires Isopanel NV to deliver integrated solutions in the cold storage panels market

  • Published on 05/29/2026 at 17:52, 2 hours 30 minutes ago

    Mandat de rachat d’actions

  • Published on 05/29/2026 at 17:52, 2 hours 30 minutes ago

    Share buyback mandate

  • Published on 05/29/2026 at 15:38, 4 hours 45 minutes ago

    Déclaration d'actions et de droits de vote au 30.04.2026

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy